Enantioselective in vitro metabolism and in vitro-in vivo correlation of the herbicide ethofumesate in a human model

An enantioselective study of the behavior of the herbicide ethofumesate in agricultural soils: Impact of the addition of organoclays and biochar

Chiral pesticides that are still commercialized and incorporated into the environment as racemic mixtures of enantiomers require evaluation of the enantioselectivity of their biological activity and environmental fate processes for a better prediction of their field efficacy and environmental risks. In this work, we successfully separated the enantiomers of the chiral herbicide ethofumesate (ETFM), determined their absolute configuration, and characterized their herbicidal activity as well as their adsorption, degradation, enantiomerization, and leaching in Mediterranean agricultural soils. While the herbicidal activity of R-ethofumesate to the sensitive species Portulaca grandiflora was greater than that of S-ethofumesate, the adsorption, degradation, and leaching of the herbicide showed negligible enantioselectivity and enantiomer interconversion did not occur in soils. The adsorption of both enantiomers showed a positive correlation with the soil organic carbon content (r = 0.856, P = 0.015), and their degradation in soils occurred slowly (DT50 > 60 days) and at similar rates independent of their application as individual enantiomers or as a racemic mixture of enantiomers. The addition of three highly adsorptive materials to a scarcely adsorptive soil increased the adsorption of the enantiomers of ETFM and delayed their degradation without affecting the non-enantioselective character of the processes. As a result of their high adsorption capacity, the materials were highly effective in reducing the leaching of both enantiomers of ETFM through soil columns. The results of this work indicate that the application of single-enantiomer ETFM formulations, based on a higher herbicidal activity or a lower toxicity to non-target organisms of the formulated enantiomer, would reduce considerable exposure risks associated with incorporating into the environment the less favorable enantiomer, as this would show long persistence and high leaching potential in soils similar to its optical isomer.

Screening of Pharmaceutical Pollutants Along with Emerging Contaminants in the Sediments of the Periyar River, Located in Kerala (India) by Using High-Resolution Mass Spectrometry (UPLC-Q-ToF-MS)

In this study, ultra-performance liquid chromatography coupled with a quadruple time-of-flight mass spectrometry (UPLC-Q-ToF-MS) was employed to screen and identify pharmaceutical pollutants and emerging contaminants (ECs) in the Periyar River near Aster Medicity hospital, the dumping yard of Amrutha hospital, and the Vaduthala bridge regions in Kerala, India. The analysis was conducted in both positive and negative ionization modes using electrospray ionization (ESI). The QuEChERS method was employed for initial sediment sample preparation. Among the twenty-five identified ECs, four compounds were identified as pharmaceutical pollutants. This study have great significance as it represents the first comprehensive investigation of pharmaceutical pollutants in these hospital regions, highlighting the urgent need for further analysis and understanding of the situation. The presence of ECs poses an urgent need for attention due to the irreversible harm caused to the riverine ecosystem by the degradation of water quality resulting from industrial and domestic discharge.

Enantioselective inhibition of human CYP2C19 by the chiral pesticide ethofumesate: Prediction of pesticide-drug interactions in humans

Ethofumesate is a chiral herbicide that may display enantioselective behavior in humans. For this reason, the enantioselective potential of ethofumesate and its main metabolite ethofumesate-2-hydroxy to cause pesticide-drug interactions on cytochrome P450 forms (CYPs) has been evaluated by using human liver microsomes. Among the evaluated CYPs, CYP2C19 had its activity decreased by the ethofumesate racemic mixture (rac-ETO), (+)-ethofumesate ((+)-ETO), and (-)-ethofumesate ((-)-ETO). CYP2C19 inhibition was not time-dependent, but a strong inhibition potential was observed for rac-ETO (IC₅₀ = 5 ± 1 μmol L^-1), (+)-ETO (IC₅₀ = 1.6 ± 0.4 μmol L^-1), and (-)-ETO (IC₅₀ = 1.8 ± 0.4 μmol L^-1). The reversible inhibition mechanism was competitive, and the inhibition constant (K_i) values for rac-ETO (2.6 ± 0.4 μmol L^-1), (+)-ETO (1.5 ± 0.2 μmol L^-1), and (-)-ETO (0.7 ± 0.1 μmol L^-1) were comparable to the K_i values of strong CYP2C19 inhibitors. Inhibition of CYP2C19 by ethofumesate was enantioselective, being almost twice higher for (-)-ETO than for (+)-ETO, which indicates that this enantiomer may be a more potent inhibitor of this CYP form. For an in vitro-in vivo correlation, the Food and Drug Administration's (FDA) guideline on the assessment of drug-drug interactions used in the early stages of drug development was used. The FDA's R₁ values were estimated on the basis of the obtained ethofumesate K_i and distribution volume, metabolism, unbound plasma fraction, gastrointestinal and dermal absorption data available in the literature. The correlation revealed that ethofumesate probably inhibits CYP2C19 in vivo for both chronic (oral) and occupational (dermal) exposure scenarios.

The enantioselective study of the toxicity effects of chiral acetochlor in HepG2 cells

Acetochlor is one of the most widely used chiral herbicides in the world, and it is usually produced and used as racemic form (Rac). The potential effects of acetochlor in human body are mainly induced by its residue in agriculture food. The direct target exposed is the liver in human body. However, the potential toxic and mechanism threat to human liver cells caused by chiral acetochlor has been rarely reported. The purpose of this study is to explore the potential mechanism of the toxicity caused by chiral acetochlor in HepG2 cells. The results revealed that acetochlor and its enantiomers could inhibit cell activity and cause DNA damage in HepG2 cells. The toxicity of Rac was higher than that of the two enantiomers, mainly derived from S configuration. The mechanism is through inducing decreased membrane potential (△Ψ), up-regulated Bax/BcL-2 expression, caused a cascade reaction, activated casepase-3 and casepase-9 and cleaved PARP, which maybe lead to cell death through apoptotic-signaling pathway in the end. These results illuminate that the genotoxic and cytotoxic risks of chiral acetochlor are major coming from S configuration. It provides a theoretical basis for the production of single pesticide to reduce the effects of human health.

Risk assessment of the chiral pesticide fenamiphos in a human model: Cytochrome P450 phenotyping and inhibition studies

Fenamiphos (FS) is a chiral organophosphate pesticide that is used to control nematodes in several crops. Enantioselective differences may be observed in FS activity, bioaccumulation, metabolism, and toxicity. Humans may be exposed to FS through occupational and chronic (food, water, and environmental) exposure. FS may cause undesirable CYP450 pesticide-drug interactions, which may impact human health. Here, the CYP450 isoforms involved in enantioselective FS metabolism were identified, and CYP450 inhibition by rac-FS, (+)-FS, and (-)-FS was evaluated to obtain reliable information on enantioselective FS risk assessment in humans. CYP3A4 and CYP2E1 metabolized FS enantiomers, and CYP2B6 may participate in rac-FS metabolism. In addition, rac-FS, (+)-FS, and (-)-FS were reversible competitive CYP1A2, CYP2C19, and CYP3A4/5 inhibitors. High stereoselective inhibition potential was verified; rac-FS and (-)-FS strongly inhibited and (+)-FS moderately inhibited CYP1A2. Stereoselective differences were also detected for CYP2C19 and CYP3A4/5, which were strongly inhibited by rac-FS, (+)-FS, and (-)-FS. Our results indicated a high potential for CYP450 drug-pesticide interactions, which may affect human health. The lack of stereoselective research on the effect of chiral pesticides on the activity of CYP450 isoforms highlights the importance of assessing the risks of such pesticides in humans.